Testing urine samples instead of bladder scope procedures

The UROSCOUT-1 trial is testing whether a urine DNA test can safely replace the need for cystoscopy—an invasive procedure where doctors look inside your bladder with a camera—in people suspected of having bladder cancer. Right now, millions of people undergo this uncomfortable procedure each year, but only 1 in 10 actually have cancer. This study will collect urine samples by mail and analyze them to see if this simpler test can detect cancer just as well.

Cystoscopy is uncomfortable, invasive, and requires special equipment and trained doctors—yet it's often unnecessary since most patients don't have cancer. The urine DNA test could be a gentler, cheaper, and easier alternative that still catches cancer when it's really there, improving life for patients and reducing strain on hospitals.